-
Evolutionary model for antibiotic resistance reveals dose timing critical to care
Cleveland Clinic researchers are working to improve the way we use evolutionary modeling to understand drug resistance. The study, published... Read more -
SGLT2 inhibitor treatment stabilizes kidney function in patients who have had a heart attack
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have... Read more -
The weight loss drug Mounjaro has been approved to treat sleep apnea. How does it work?
Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which... Read more -
How toxic are softgel capsules?
Softgel capsules—the smooth, easy-to-swallow form of many medications and supplements—are increasingly popular for delivering everything from vitamins to omega-3s. These... Read more -
Germany's BioNTech to buy CureVac to boost cancer research
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized... Read more -
FDA approves polypill Widaplik for hypertension
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension... Read more -
Prolonged use of desogestrel pill linked to small increased brain tumor risk
Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of... Read more -
Doctors raise concern over rise in recreational ketamine use
The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in... Read more -
Researchers challenge FDA warning on common epilepsy drug
Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults with epilepsy, contrary... Read more -
Drug combination shows promise for early treatment after myocardial infarction
Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the... Read more -
Once-a-week pill for schizophrenia shows promise in clinical trials
For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be difficult to... Read more -
Combination approach could overcome treatment resistance in deadly breast cancer
QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with... Read more -
A repurposed heart arrhythmia drug shows promise in killing antibiotic-resistant bacteria
A new study from Emory University addresses the growing global crisis of antibiotic-resistant infections. Many of these drug-resistant bacteria are... Read more -
Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting... Read more -
Deliberately infected participants lead to penicillin advance
A unique study purposely giving participants Streptococcus pyogenes (Strep A) to learn how much penicillin it takes to prevent infection... Read more
